Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PN 200 or Naproxen in Subjects Who Are at Risk for Developing NSAID-Associated Ulcers.

NCT00367211 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis
Rheumatoid Arthritis
Ankylosing Spondylitis

Interventions

DRUG: PN 200 tablets (500 mg naproxen and 20 mg omeprazole)
DRUG: Naproxen 500 mg tablets (PN 200 minus omeprazole)

Sponsor

POZEN